Table 2.
125I-labelled angiotensin II (Ang II) binding characteristics of glomeruli from control and low-protein (LP) rats
Control | LP | |
---|---|---|
Bmax | ||
125I-Ang II | 291.6 ± 27.4 | 445.7 ± 27.4† |
125I-Ang II and losartan | 44.4 ± 5.89 | 26.3 ± 3.85* |
125I-Ang II and PD123319 | 217.4 ± 16.3 | 370.5 ± 19.7‡ |
KD | ||
125I-Ang II | 2.87 ± 0.85 | 0.84 ± 0.20 |
125I-Ang II and losartan | 2.45 ± 1.06 | 0.74 ± 0.45 |
125I-Ang II and PD123319 | 2.19 ± 0.55 | 0.73 ± 0.16* |
The binding constant (Bmax, expressed in femtomoles per milligram glomerular protein) and binding affinity (KD, expressed in picomoles of 125I-Ang II) are shown for 125I-Ang II alone (10−10–10−7m, control n = 9 from 6 litters, LP n = 7 from 6 litters), 125I-Ang II plus the AT1 receptor antagonist losartan (10−4m, control n = 7 from 5 litters, LP n = 7 from 5 litters) and 125I-Ang II plus the AT2 receptor antagonist PD123319 (10−4m, control n = 7 from 5 litters, LP n = 7 from 5 litters). Data are presented as means ±s.e.m. Statistical comparisons were by one-way ANOVA and Duncan's test. Differences between control and LP glomeruli treated in the same manner are shown
(P < 0.05,
P < 0.01,
P < 0.001); for comparisons between different treatments see the results text.